A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19
Year: 2025
Type: article
Language: en
Topic: COVID-19 and healthcare impacts
Authors and affiliations:
raw_author_name: Liting Guo
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Chenfei Zhou
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Wenqi Xi
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Liu Yang
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Qing Chang
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Qing Qu
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Jinling Jiang
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Junwei Wu
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Qu Cai
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Jun Yan
raw_affiliation_strings: Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences
Department of Oncology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China
raw_author_name: Chun Wang
raw_affiliation_strings: Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences
Department of Oncology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China
raw_author_name: Yanzhi Bi
raw_affiliation_strings: Changzhou Tumor Hospital Affiliated to Soochow University
Department of Oncology, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou, China
raw_author_name: Xuyang Wen
raw_affiliation_strings: Haowangjiao Hospital
The 82nd Hospital of the PLA
Department of Oncology, The 82nd Hospital of the PLA, Huaian, Jiangsu, China
Department of Oncology, Haowangjiao Hospital, Shanghai, China
raw_author_name: Feng Qi
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
raw_author_name: Jun Zhang
raw_affiliation_strings: Shanghai Jiao Tong University School of Medicine
Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China